JPRN-UMIN000014186
Completed
未知
The effect of a mineralocorticoid receptor antagonist eplerenone on morning home BP in drug-resistant hypertension - Eplerenone study
Jichi Medical University School of Medicine0 sites100 target enrollmentJune 20, 2014
Conditionsdrug-resistant morning hypertension
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- drug-resistant morning hypertension
- Sponsor
- Jichi Medical University School of Medicine
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Diabetes with albuminuria or proteinuria 2\.Allergy, or allergic reaction to study drugs 3\. Patients with Hyperkalemia or serum potassium level\>5\.0mEq/ 4\.Renal dysfunction (Ccr\<50ml/min) 5\.Sevre Hepatic damage 6\.Taking potassium, or spironolactone 7\.Taking Itraconazole, Ritonavir, and Nelfinavir 8\. age\<20yrs, or dementia 9\. Not appropriate for the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Effects of mineralocorticoid receptor antagonist on intradialytic hypertension: a multicenter, double-blind, randomized crossover studyIntradialytic hypertensionSpironolactoneMineralocorticoid receptor antagonistTCTR20200604013ampang hospital49
Completed
Not Applicable
Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronismPrimary aldosteronismJPRN-UMIN000037657Tokyo Women's Medical University Hospital100
Completed
Phase 2
Effects of mineralocorticoid receptor agonist on intradialytic hypotension: an open-label, randomized crossover studyIntradialytic hypotensionMineralocorticoid receptor agonistTCTR20200128004ampang hospital10
Active, not recruiting
Phase 1
Effects of mineralocorticoid receptor stimulation on cognitive bias and social cognition in patients with major depression and healthy controls: what’s the role of NMDA receptors?depressed patients and healthy control subjectsTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2014-005239-15-DECharité - Universitätsmedizin Berlin232
Completed
Not Applicable
Effect of spironolactone on ischemia reperfusion injury in renal transplant recipientsIschemia reperfusion injuryCirculatory SystemISRCTN01577227Mexican Council of Science and Technology (Consejo Nacional de Ciencia y Tecnología CONACyT) (Mexico)60